Navigation Links
Medco Issues $1.5 Billion of Senior Notes
Date:3/13/2008

FRANKLIN LAKES, N.J., March 13 /PRNewswire-FirstCall/ -- Medco Health Solutions, Inc. (NYSE: MHS) announced today that it has agreed to sell $300 million aggregate principal amount of 6-1/8 percent senior notes due March 15, 2013 and $1.2 billion aggregate principal amount of 7-1/8 percent senior notes due March 15, 2018 in an underwritten public offering. Citi, J.P. Morgan Securities Inc., Banc of America Securities LLC and Barclays Capital Inc. are acting as representatives of the several underwriters.

Medco intends to use the net proceeds from the offering to repay borrowings under its senior unsecured revolving credit facility used to fund the acquisition of PolyMedica Corporation in October 2007. The offering is expected to close on March 18, 2008. The prospectus supplement and accompanying prospectus related to the offering of the notes may be obtained by contacting:

Citigroup Global Markets Inc.

Brooklyn Army Terminal,

140 58th Street, 8th Floor,

Brooklyn, NY 11220

Tel: (877) 858 5407

J.P. Morgan Securities Inc.

270 Park Avenue, 8th Floor,

New York, New York, 10017

Tel: (212) 834-4533

Banc of America Securities LLC

Capital Markets Operations

100 West 33rd Street, 3rd Floor

New York, NY 10001

Tel: (800) 294-1322

Barclays Capital Inc.

200 Park Avenue

New York, NY 10166

Attention: Fixed Income Syndicate

Tel: (888) 227-2275

Electronic copies of the prospectus supplement and accompanying prospectus are also available on the Securities and Exchange Commission Web site at http://www.sec.gov.

This press release does not constitute an offer to sell
'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Addressing the Pharmacist Shortage: Medco Labor Coalition(TM) Launches National Scholarship Program to Support the Development of the Next Generation of Pharmacists
2. Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the Worlds Largest, Most-Advanced Automated Pharmacy
3. Medco to Webcast Annual Analyst Day Conference
4. Medco Announces Agreement to Acquire Diabetes Care Leader PolyMedica in Transaction Valued at $1.5 Billion
5. SectorWatch.biz Issues MarketStats on CVBT, BSX, MDT, CXM and DNA
6. Solstice Neurosciences, Inc. Issues Corporate Response to FDA Early Communication
7. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
8. Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
9. FDA Issues Approvable Letter for LUVOX(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
10. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants
11. CCPM Issues Statement on FDAs GIVE Initiative

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2009)...at the National Institute of Standards and Technol...nexpensive method for detecting and measuring elus...s, invisible spoilage in food or pesticides distri...od is more sensitive than conventional techniques ... polarlike water molecules, having distinct electr...
(Date:11/18/2009)...RICHMOND, Calif., Nov. 18 /PRNewswire-FirstCall/ -...nced today that data from the University of Pennsy... of Sangamo,s zinc finger nuclease (ZFN) based pro...d prematurely disclosed on the internet. ,, Dat...sity of Pennsylvania School of Medicine from a sin...
(Date:11/18/2009)..., NEW YORK, Nov. 18 Reportlinker...s available in its catalogue. ,, Biotechnolog... http://www.reportlinker.com/p0164375/Biotechnolog...source=prnewswire&utm_medium=pr&utm_campai...gy are complex chemical compounds used in a range ...
(Date:11/18/2009)...VT-111 significantly reduces key cardiac enzymes a... presented at American Heart Association 2009 Scie...wire/ - Viron Therapeutics Inc., a biotechnology c...ting protein therapeutics derived from pathogens, ...rial evaluating VT-111 (Serp-1), an anti-inflammat...
Breaking Biology Technology:Prototype NIST method detects and measures elusive hazards 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 3Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 4
...looking for an ambitious mission statement, consid...l Finance Adequacy Initiative: "We will not simply...ars, but propose a complete new reuse of all dolla...ol) system, and then any additional dollars if tha...om Still is a member of the initiative] , ,In oth...
... Wis. The Eau Claire Area Economic Development ...rting up again, offering cash awards of up to $10,...nty. , ,For interested entrepreneurs, the EDC is h...en entrants in the Creating Your Own Business Con...ications. , ,Businesses judged to have the best pl...
...now you,ve had a chance to absorb all the news fro...ators, stage presentations here -- click on DEMO... a company). , ,One question that always swirls ar...t want to know what wasn,t at DEMO. The premise of...at hundreds of products and companies and bring on...
Other Biology Technology:Measuring what works and what doesn't in the prototypical school 2Measuring what works and what doesn't in the prototypical school 3Why companies don't get invited to the DEMO conference 2Why companies don't get invited to the DEMO conference 3
(Date:11/21/2009)...ed, Germany, November 20,2009 / b3c newswire / -...tion of a financing round, gaining two new investo...he same time KINAXO reports that Jrgen Schumacher ...dvisory board. , KINAXO shareholders Axel Ullric... companys institutional investors Mountain Partner...
(Date:11/20/2009)...researchers are at work on many scientific and tec...ion has recently provided support that totals near...lowing investigators under the American Recovery a...s have been awarded grants for investigation of so...essor of physics, will enhance the capabilities of...
(Date:11/20/2009)...search report published in the November 2009 issue...rg ), scientists show how a family of genes (1-ami...s) are responsible for production of ethylene. Thi...nd this information lays the foundation for future...se resistant, able to survive and thrive in diffic...
Breaking Biology News(10 mins):KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2It's a gas: New discovery may lead to heartier, high-yielding plants 2Cleveland Lawyers Recognized by Peers on The Best Lawyers in America List 57298 1Cleveland Lawyers Recognized by Peers on The Best Lawyers in America List 57298 2Cleveland Lawyers Recognized by Peers on The Best Lawyers in America List 57298 3Top 15 Pharmaceutical Company Awards Cardiac Safety Study to iCardiac 14069 1Top 15 Pharmaceutical Company Awards Cardiac Safety Study to iCardiac 14069 2ISSA Recognized as Military Friendly School 57294 1ISSA Recognized as Military Friendly School 57294 2
...N, Va., Nov. 18 Stanley, Inc.,(NYSE: SXE ), a l...ional,services to the U.S. federal government, tod...ence Applications International Corporation (NYSE:...task order valued at up to $37.9 million, if,all t...the team will continue,to provide in-service engin...
...BRUNSWICK, N.J. Families gathering around the Tha... side dish that,s been given some "upscale" breedi...he age-old staple will look or taste no different ...elping growers increase production and improve fru...elping them meet the increasing year-round demand ...
...ork, NY, November 18, 2008 -- Researchers at the U...ed that two common cancer drugs have been used to ...F-funded study, published in The Proceedings of t...ey Bluestone, Ph.D., director of the Diabetes Cent...ity. , "The findings suggest that kinase inhibito...
Other Biology News:Stanley to Continue Biometrics In-Service Engineering Support for U.S. Army 2Stanley to Continue Biometrics In-Service Engineering Support for U.S. Army 3Favorite Thanksgiving dish gets 'upscale' breeding 2
Chaperone Sampler Kit from BD Biosciences Pharmingen
Zonula Adherens Sampler Kit from BD Biosciences Pharmingen
Tumor Suppressor Sampler Kit from BD Biosciences Pharmingen
UCB Eosinophil Chip-IHC from 3H Biomedical AB
Biology Products: